RecruitingNCT02647879

Treatment as Prevention for Hepatitis C in Iceland

Treatment as Prevention for Hepatitis C in Iceland. A Nationwide Campaign for Reducing Disease Burden Using Combination Antiviral Treatment


Sponsor

Landspitali University Hospital

Enrollment

1,000 participants

Start Date

Jan 1, 2016

Study Type

OBSERVATIONAL

Conditions

Summary

The main aim of this study is to test in the Icelandic population the hypothesis that a nationwide treatment program which offers effective treatment to all known cases of Hepatitis C with the aim of halting HCV (Hepatitis C virus) transmission will lead to a reduction in incidence and disease burden associated with chronic HCV infection.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study in Iceland is testing whether treating ALL people infected with hepatitis C (a liver virus) — including those who use drugs — with antiviral medications can dramatically reduce and eventually eliminate hepatitis C from the population (a strategy called treatment as prevention). **You may be eligible if...** - You are living in Iceland and have been diagnosed with hepatitis C - You are willing to be treated with antiviral medications for hepatitis C - You are willing to participate in follow-up testing and monitoring **You may NOT be eligible if...** - You do not have an active hepatitis C infection - You have already been successfully treated for hepatitis C - You have a serious medical condition that prevents you from taking the study medications - You are pregnant (depending on the specific drug regimen) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Landspitali

Reykjavik, Iceland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02647879


Related Trials